Pharmacogenomics (PGX) aims to individualize therapy upon patients’ unique DNA profiles. IMGGE (Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia) is a pioneer in the PGX in the Western Balkans (WB). Through PharmGen HUB project IMGGE will become WB central place for PGX diagnostics and R&I, education and trainings, and translation of PGX knowledge into clinically applicable digital solutions.
